KATHRYN WEST-PFINGSTON: Open Payments
NPI 1093173627 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 40 payments from 14 companies in 2025. Trend: 2023 $3,776 · 2024 $4,243 · 2025 $1,103
Food & beverage: $809Education: $293
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $208 |
| Regeneron Healthcare Solutions, Inc. | 6 | $181 |
| Janssen Biotech, Inc. | 3 | $142 |
| Lilly USA, LLC | 2 | $128 |
| GENZYME CORPORATION | 5 | $81 |
| ABBVIE INC. | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| UCB, Inc. | 3 | $61 |
| Incyte Corporation | 2 | $49 |
| Galderma Laboratories, L.P. | 2 | $30 |
Products named: DUPIXENT, TREMFYA, EBGLYSS, ILUMYA, COSENTYX, Bimzelx, SKYRIZI, OPZELURA.
Industry payments across KY — which companies pay providers there.
